Silo Pharma (SILO) 10-Q2016 Q1 Quarterly report

Filed: 31 Aug 16, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. freshman Avg

New words: absence, administer, agency, agreed, amortization, Appreciationon, arise, automatically, Baby, borrower, Brand, breach, CAKE, cancel, canceled, category, cease, characterization, charged, Committee, compliance, comprising, conflicting, connection, consent, contract, contravention, COSO, criteria, decided, dedicated, default, degree, delinquent, deteriorate, digital, dilution, discretion, doubt, DRIO, EBITDA, enzyme, Eric, extension, fact, feasible, Frameworkissued, harm, hereunder, hired, history, Hybrid, inception, inherited, inInternal, intracellular, issuer, Labstyle, light, liver, long, lose, membership, middle, mRNA, mutual, optimizing, order, outsourced, par, part, percentage, permanent, Phase, phaserx, Pish, Posh, PPB, preceding, preclinical, proprietary, purpose, reclassification, registered, release, released, remediate, replacement, Richard, Rx, segregation, size, strategic, support, susceptible, TechnologyTM, terminate, therapy, Treadway, unadjusted, variable, VIE, Weisblum, whichever, written, yield

Removed: adjustment, Arch, artificially, authority, award, Basin, bid, calculate, calculated, consistent, daily, decision, deemed, Dejour, determine, director, discussed, effort, employee, entered, entity, expiring, fixed, gas, grant, granted, historical, independent, inflated, instrument, intrinsic, issue, jurisdiction, larger, life, maximum, memorandum, month, monthly, national, natural, North, oil, partial, Peace, Piceance, policy, PPM, preparing, production, ready, recognition, Regulation, requiring, requisite, River, spread, strike, subjective, sustained, thereof, thereunder, thinly, threshold, treasury, uncertain, underlying, unrecognized, unvested, utilized, vest, vesting, weekly

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SILO similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with this quarterly report on Form 10-Q of Point Capital, Inc. (the “Company”) for the period ended March 31, 2016 as filed with the Securities and Exchange Commission (the “Report”), I, Eric Weisblum, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

Date: August 30, 2016

By:	/s/ Eric Weisblum
Name:	Eric Weisblum
Title:	Chairman, Chief Executive Officer and Director (principal executive officer)

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.